Skip to content
Screener

SELLAS Life Sciences Group, Inc. SLS Q3 2025 earnings

Reported November 12, 2025 · Before market open

EPS-$0.06Beat by $0.00
EPS estimate-$0.06

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.05

Financials

Q3 2025

Income statement

See full
Operating income-$7.1M+3.4%
Net income-$6.8M+4.5%
EPS (diluted)-$0.06+40.0%

Balance sheet

See full
Cash & equivalents$44.3M+111%
Total debt$500.0K0.0%
Total equity$45.6M+187%
Total assets$51.6M+94.5%

Cash flow

See full
Operating cash flow-$7.1M+9.5%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$201.22M+150%
Enterprise value$157.4M+163%

Returns & leverage

See full
Return on equity-84.3%—
Debt / equity0×0.0×
Current ratio8.3×+6.0×

FAQ

When did SELLAS Life Sciences Group, Inc. report Q3 2025 earnings?
SELLAS Life Sciences Group, Inc. (SLS) reported Q3 2025 earnings on November 12, 2025 before market open.
What were SELLAS Life Sciences Group, Inc.'s Q3 2025 revenue and EPS?
SELLAS Life Sciences Group, Inc. reported eps of $-0.06 for Q3 2025.
Did SELLAS Life Sciences Group, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.06 by $0.00.
How did SELLAS Life Sciences Group, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 40.0% from $-0.10.
Where can I find SELLAS Life Sciences Group, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001390478-25-000021) and the 10-Q periodic report (0001390478-25-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.